Correlation Between Alphabet and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Alphabet and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Nuvectis Pharma, you can compare the effects of market volatilities on Alphabet and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Nuvectis Pharma.
Diversification Opportunities for Alphabet and Nuvectis Pharma
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alphabet and Nuvectis is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Alphabet i.e., Alphabet and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Alphabet and Nuvectis Pharma
Given the investment horizon of 90 days Alphabet is expected to generate 3.84 times less return on investment than Nuvectis Pharma. But when comparing it to its historical volatility, Alphabet Inc Class C is 3.36 times less risky than Nuvectis Pharma. It trades about 0.2 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 541.00 in Nuvectis Pharma on November 1, 2024 and sell it today you would earn a total of 133.00 from holding Nuvectis Pharma or generate 24.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alphabet Inc Class C vs. Nuvectis Pharma
Performance |
| Timeline |
| Alphabet Class C |
| Nuvectis Pharma |
Alphabet and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and Nuvectis Pharma
The main advantage of trading using opposite Alphabet and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.The idea behind Alphabet Inc Class C and Nuvectis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |